425 related articles for article (PubMed ID: 8262311)
21. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
[TBL] [Abstract][Full Text] [Related]
22. Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type I diabetes.
Yu L; Gianani R; Eisenbarth GS
Diabetes; 1994 Oct; 43(10):1229-33. PubMed ID: 7926293
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
Kretowski A; Szelachowska M; Kinalska I
Pol Arch Med Wewn; 1999 Apr; 101(4):323-7. PubMed ID: 10740410
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
25. No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM.
Roll U; Nuber A; Schröder A; Gerlach E; Janka HU; Ziegler AG
Diabetes Care; 1995 Feb; 18(2):210-5. PubMed ID: 7729299
[TBL] [Abstract][Full Text] [Related]
26. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
Yang L; Zhou ZG; Huang G; Yan X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
[TBL] [Abstract][Full Text] [Related]
27. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
Borg H; Fernlund P; Sundkvist G
Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455
[TBL] [Abstract][Full Text] [Related]
28. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
[TBL] [Abstract][Full Text] [Related]
29. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.
Velloso LA; Kämpe O; Hallberg A; Christmanson L; Betsholtz C; Karlsson FA
J Clin Invest; 1993 May; 91(5):2084-90. PubMed ID: 8486775
[TBL] [Abstract][Full Text] [Related]
30. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.
Bingley PJ; Williams AJ; Gale EA
Diabetes Care; 1999 Nov; 22(11):1796-801. PubMed ID: 10546010
[TBL] [Abstract][Full Text] [Related]
31. Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large french cohort of family members.
Thivolet C; Nicolino M; Monbeig S; Estour B; Halimi S; Robert M; Orgiazzi J; Chatelain P;
Diabetes Metab; 2002 Sep; 28(4 Pt 1):279-85. PubMed ID: 12442065
[TBL] [Abstract][Full Text] [Related]
32. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus.
Imagawa A; Itoh N; Hanafusa T; Katsura H; Yamaguchi A; Takeda A; Iwahashi H; Nakajima H; Miyagawa J; Namba M; Kuwajima M; Matsuzawa Y
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):43-52. PubMed ID: 8733827
[TBL] [Abstract][Full Text] [Related]
34. [Islet autoantibody assays in type I diabetes: superiority of passage from use of ICA to traditional tests].
Lazar D; Weintrob N; Abramov N; Assa S; Bloch K; Ofan R; Ben-Zaken H; Vardi P
Harefuah; 1998 May; 134(9):678-81, 750. PubMed ID: 10909610
[TBL] [Abstract][Full Text] [Related]
35. Diabetes mellitus-related autoantibodies in childhood autoimmune hepatitis.
da Silva ME; Porta G; Goldberg AC; Bittencourt PL; Fukui RT; Correia MR; Miura IK; Pugliese RS; Baggio VL; Cançado EL; Kalil J; Santos RF; Rochal DM; Wajchenberg BL; Ursich MJ; Rosenbloom AL
J Pediatr Endocrinol Metab; 2002 Jun; 15(6):831-40. PubMed ID: 12099394
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.
Alves LI; Davini E; Correia MR; Fukui RT; Santos RF; Cunha MR; Rocha DM; Volpini WM; Silva ME
J Clin Immunol; 2012 Aug; 32(4):778-85. PubMed ID: 22402866
[TBL] [Abstract][Full Text] [Related]
38. Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.
Thivolet C; Beaufrére B; Bétuel H; Gebuhrer L; Chatelain P; Durand A; Tourniaire J; François R
Diabetologia; 1988 Oct; 31(10):741-6. PubMed ID: 3071483
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives.
Chen QY; Rowley MJ; Byrne GC; Jones TW; Tuomi T; Knowles WJ; Zimmet PZ; Mackay IR
Pediatr Res; 1993 Dec; 34(6):785-90. PubMed ID: 8108194
[TBL] [Abstract][Full Text] [Related]
40. Quantification of human cytoplasmic islet-cell antibodies which cross-react with mouse pancreas: a follow-up study in type 1 (insulin-dependent) diabetic patients and in first-degree relatives.
Saï P; Elmansour A; Audrain M; Charbonnel B; Bardet S
Diabetologia; 1993 Aug; 36(8):778-84. PubMed ID: 8405747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
